Clinical application of radial hemostat after emergency percutaneous coronary intervention
ZHAO Bing
LIU Jian-guo
LI Jun-xia
BAO Hong-gang
Abstract：Objective To observe the clinical efficacy and safety of radial hemostat for pressure hemostasis in patients with acute ST-segment elevation myocardial infarction (STEMI) after direct emergency percutaneous coronary intervention (PCI). Methods The patients (n=124) with successful emergency PCI by radial approach were given aspirin and clopidogrel loading before PCI and radial sheath was kept for 6 h after direct PCI. RDP700 forearm straight radial hemostat (produced by Zeon Corporation) was used for pressure hemostasis, and the clinical efficacy and safety were reviewed. The influences of sex, age, weight and tirofiban on pressure time of hemostat and swelling subsiding time of distal limb were observed. Results All 124 patients had successful immediate hemostasis, and the mean pressure time was (9.9±3.5) h and mean swelling subsiding time of distal limb was (32.4±8.7) h. There were 3 cases (2.4%) had radial occlusion and 5 (4.0%) had skin lesion at puncture focus. Compared with male patients, the pressure time of radial hemostat and swelling subsiding time of distal limb were significantly prolonged (all P<0.01). The pressure time of radial hemostat and swelling subsiding time of distal limb were significantly prolonged in patients aged≥60 and weighed<65 kg (all P<0.01), and also significantly prolonged in patients been given tirofiban compared with those without giving it after direct PCI (all P<0.01). Conclusion The radial hemostat for pressure hemostasis is safe and effective in patients with emergency PCI, and sex, age, weight and tirofiban have influences on pressure time of radial hemostat and swelling subsiding time of distal limb.
Keywords：Percutaneous coronary interventionRadial arteryHemostat
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 108-110 )